2023 annual financial data
BioRestorative Therapies 2023 Revenue growth
Direct answer
Revenue growth was 21.7%.
Operating income was -15,220,774 USD and net income was -10,417,704 USD.
Operating cash flow was -6,430,211 USD.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 145,800 USD
- Operating income
- -15,220,774 USD
- Net income
- -10,417,704 USD
- Operating cash flow
- -6,430,211 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all BioRestorative Therapies financial years